Entropy Technologies, LP Altimmune, Inc. Transaction History
Entropy Technologies, LP
- $925 Billion
- Q2 2024
A detailed history of Entropy Technologies, LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 24,635 shares of ALT stock, worth $166,532. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,635
Previous 34,527
28.65%
Holding current value
$166,532
Previous $351 Million
53.39%
% of portfolio
0.02%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ALT
# of Institutions
188Shares Held
42.3MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$33.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$26.4 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$21.8 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$18.6 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $331M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...